Barclays’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-176,444
| Closed | -$547K | – | 5868 |
|
|
2021
Q4 | $547K | Buy |
176,444
+10,392
| +6% | +$35K | ﹤0.01% | 3164 |
|
|
2021
Q3 | $599K | Buy |
166,052
+34,456
| +26% | +$130K | ﹤0.01% | 3097 |
|
|
2021
Q2 | $470K | Sell |
131,596
-62,201
| -32% | -$219K | ﹤0.01% | 3107 |
|
|
2021
Q1 | $757K | Buy |
193,797
+27,056
| +16% | +$112K | ﹤0.01% | 2940 |
|
|
2020
Q4 | $701K | Buy |
166,741
+148,374
| +808% | +$572K | ﹤0.01% | 3011 |
|
|
2020
Q3 | $69K | Sell |
18,367
-196,583
| -91% | -$837K | ﹤0.01% | 4444 |
|
|
2020
Q2 | $937K | Buy |
214,950
+214,027
| +23,188% | +$962K | ﹤0.01% | 2823 |
|
|
2020
Q1 | $3K | Buy |
923
+644
| +231% | +$3.17K | ﹤0.01% | 6009 |
|
|
2019
Q4 | $2K | Sell |
279
-40,975
| -99% | -$241K | ﹤0.01% | 6259 |
|
|
2019
Q3 | $173K | Sell |
41,254
-16,896
| -29% | -$72.2K | ﹤0.01% | 5079 |
|
|
2019
Q2 | $270K | Sell |
58,150
-208,769
| -78% | -$972K | ﹤0.01% | 4839 |
|
|
2019
Q1 | $1.42M | Sell |
266,919
-61,120
| -19% | -$279K | ﹤0.01% | 3008 |
|
|
2018
Q4 | $1.21M | Buy |
328,039
+296,582
| +943% | +$1.04M | ﹤0.01% | 2919 |
|
|
2018
Q3 | $88K | Hold |
31,457
| – | – | ﹤0.01% | 5682 |
|
|
2018
Q2 | $93K | Sell |
31,457
-20,912
| -40% | -$49.6K | ﹤0.01% | 5300 |
|
|
2018
Q1 | $118K | Sell |
52,369
-20,017
| -28% | -$46.9K | ﹤0.01% | 5263 |
|
|
2017
Q4 | $213K | Buy |
72,386
+72,329
| +126,893% | +$200K | ﹤0.01% | 4641 |
|
|
2017
Q3 | $0 | Hold |
57
| – | – | ﹤0.01% | 7325 |
|
|
2017
Q2 | $0 | Hold |
57
| – | – | ﹤0.01% | 7279 |
|
|
2017
Q1 | $0 | Hold |
57
| – | – | ﹤0.01% | 7261 |
|
|
2016
Q4 | $0 | Hold |
57
| – | – | ﹤0.01% | 7123 |
|
|
2016
Q3 | $0 | Sell |
57
-5,676
| -99% | -$14.4K | ﹤0.01% | 7093 |
|
|
2016
Q2 | $13K | Sell |
5,733
-3,424
| -37% | -$9.45K | ﹤0.01% | 5464 |
|
|
2016
Q1 | $27K | Sell |
9,157
-91,389
| -91% | -$338K | ﹤0.01% | 5104 |
|
|
2015
Q4 | $402K | Buy |
100,546
+2,605
| +3% | +$14.8K | ﹤0.01% | 3375 |
|
|
2015
Q3 | $490K | Buy |
97,941
+91,474
| +1,414% | +$675K | ﹤0.01% | 3359 |
|
|
2015
Q2 | $45K | Buy |
6,467
+5,211
| +415% | +$44.8K | ﹤0.01% | 5227 |
|
|
2015
Q1 | $12K | Sell |
1,256
-4,580
| -78% | -$62.6K | ﹤0.01% | 6160 |
|
|
2014
Q4 | $70K | Sell |
5,836
-35,840
| -86% | -$545K | ﹤0.01% | 5464 |
|
|
2014
Q3 | $708K | Buy |
41,676
+40,900
| +5,271% | +$594K | ﹤0.01% | 3648 |
|
|
2014
Q2 | $9K | Sell |
776
-759
| -49% | -$7.2K | ﹤0.01% | 6918 |
|
|
2014
Q1 | $12K | Buy |
1,535
+872
| +132% | +$7.04K | ﹤0.01% | 6868 |
|
|
2013
Q4 | $3K | Sell |
663
-459
| -41% | -$2.37K | ﹤0.01% | 7335 |
|
|
2013
Q3 | $6K | Sell |
1,122
-7,943
| -88% | -$38.2K | ﹤0.01% | 6962 |
|
|
2013
Q2 | $37K | Buy |
+9,065
| New | +$42.5K | ﹤0.01% | 6519 |
|
Other funds holding BDSI
Barclays's BDSI Position: Q1 2022 in Review
Barclays sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 176,444 shares — an estimated $547K sold.
Barclays first reported a position in BDSI in Q2 2013 and held it in 35 quarters. The position peaked at $1.42M in Q1 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Barclays reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Barclays sold 176,444 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $547K.
- Barclays first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 35 quarters.
- Barclays's BioDelivery Sciences International, Inc. position peaked at $1.42M in Q1 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.